期刊文献+

肝纤维化治疗:从传统方法到纳米材料递送系统

Therapy of liver fibrosis:From conventional approaches to nanomaterials delivery systems
原文传递
导出
摘要 Liver diseases seriously affect human health.Metabolic dysfunction-associated steatohepatitis(MASH)is a highly prevalent chronic liver disease that has a global prevalence of 32.4%,but this is increasing at an alarming rate[1].Cirrhosis is the 11th most common cause of death worldwide,and there was a 47%increase in mortality between 2010 and 2021[2].
作者 陈琳 段禹 姜婷婷 毛春 朱新华 万密密 Lin Chen;Yu Duan;Tingting Jiang;Chun Mao;Xinhua Zhu;Mimi Wan(National and Local Joint Engineering Research Center of Biomedical Functional Materials,School of Chemistry and Materials Science,Nanjing Normal University,Nanjing 210023,China;Department of Hepatobiliary Surgery,Affiliated Drum Tower Hospital,Medical School of Nanjing University,Nanjing 210093,China)
出处 《Science Bulletin》 SCIE EI CAS CSCD 2024年第12期1829-1832,共4页 科学通报(英文版)
基金 supported by the National Natural Science Foundation of China(22175096 and 22275095) Jiangsu Key Laboratory of Biofunctional Materials,Jiangsu Collaborative Innovation Center of Biomedical Functional Materials the Qinglan Project Foundation of Colleges and Universities of Jiangsu Province。
  • 相关文献

参考文献1

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部